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he 
 
 
 
3 integrin cytoplasmic domain, and speciﬁcally
 
S
 
752
 
, is critical for integrin localization and osteoclast
(OC) function. Because growth factors such as mac-
rophage colony–stimulating factor and hepatocyte growth
factor affect integrin activation and function via inside-out
signaling, a process requiring the 
 
 
 
 integrin cytoplasmic
tail, we examined the effect of these growth factors on OC
precursors. To this end, we retrovirally expressed various
 
 
 
3 integrins with cytoplasmic tail mutations in 
 
 
 
3-deﬁcient
OC precursors. We ﬁnd that S
 
752
 
 in the 
 
 
 
3 cytoplasmic tail
is required for growth factor–induced integrin activation,
cytoskeletal reorganization, and membrane protrusion,
T
 
thereby affecting OC adhesion, migration, and bone resorp-
tion. The small GTPases Rho and Rac mediate cytoskeletal
reorganization, and activation of each is defective in OC
precursors lacking a functional 
 
 
 
3 subunit. Activation of
the upstream mediators c-Src and c-Cbl is also dependent
on 
 
 
 
3. Interestingly, although the FAK-related kinase Pyk2
interacts with c-Src and c-Cbl, its activation is not disrupted
 
in the absence of functional 
 
 
 
3. Instead, its activation is
dependent upon intracellular calcium, and on the 
 
 
 
2 integrin.
Thus, the 
 
 
 
3 cytoplasmic domain is responsible for activation
of speciﬁc intracellular signals leading to cytoskeletal reor-
ganization critical for OC function.
 
Introduction
 
Osteoclastic bone resorption is a process requiring physical
intimacy between the resorptive cell and bone matrix. Thus,
cell–matrix attachment molecules, particularly integrins,
play a central role in the capacity of osteoclasts (OCs) to
degrade bone (Carron et al., 2000; Feng et al., 2001). The
integrin 
 
 
 
v
 
 
 
3 is particularly important, in this regard, as its
absence prompts OC dysfunction, eventuating in subnormal
bone resorption and osteosclerosis (McHugh et al., 2000).
The clinical significance of this observation is underscored
by the fact that rats treated with an 
 
 
 
v
 
 
 
3 antagonist are
spared the bone loss attending oophorectomy (Engleman et
al., 1997).
While serving as a matrix attachment molecule in OCs,
 
 
 
v
 
 
 
3 is also a signaling receptor (Eliceiri et al., 1998;
Duong et al., 2000) that induces changes in intracellular
calcium (Paniccia et al., 1993; Zimolo et al., 1994), protein
tyrosine phosphorylation, and cytoskeletal reorganization
(Clark et al., 1998; Schlaepfer and Hunter, 1998). The signal-
ing capacity of integrins can be regulated by extracellular
matrix molecules that, interacting with the integrin external
domain, stimulate “outside-in” signaling (Takagi et al., 2002).
Alternatively, “inside-out” signaling is induced by trans-
activated intracellular molecules, which interact with the
cytoplasmic component of 
 
 
 
v
 
 
 
3 and prompt conforma-
tional changes in the integrin’s ligand binding site. Outside-in
and inside-out signals control the affinity state of the integrin,
thereby modulating its binding capabilities and, ultimately,
intracellular events (Pelletier et al., 1995; Geiger et al., 2001;
Butler et al., 2003). Several cytokines and growth factors
enhance integrin-dependent intracellular events, via inside-
out signaling. Platelet-derived growth factor induces 
 
 
 
v
 
 
 
3-
mediated adhesion in fibroblasts (Schneller et al., 1997),
basic fibroblast growth factor augments migration in vascular
endothelial cells (Kiosses et al., 2001), and macrophage colony–
stimulating factor (M-CSF) and hepatocyte growth factor
(HGF) modulate OC function, in part by increasing activated
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v
 
 
 
3 in the motile area of the membrane (Faccio et al.,
2002).
In most cells, 
 
 
 
v
 
 
 
3 localizes with actin and other cyto-
skeletal proteins in focal adhesions (Ballestrem et al., 2001;
Cukierman et al., 2001). OCs contain a related, but distinct,
adhesive structure called the podosome, which consists of a
core of F-actin bundles surrounded by a rosette-like struc-
ture containing 
 
 
 
v
 
 
 
3, vinculin, and 
 
 
 
-actinin (Marchisio et
al., 1988). As ligand activation of 
 
 
 
v
 
 
 
3 and growth factor
stimulation promote podosome reorganization (Pfaff and
Jurdic, 2001; Faccio et al., 2002), interest has turned to the
intracellular components of the integrin and the signaling
molecules linking it to cytoskeletal proteins.
c-Src is essential to OC function, as mice deleted of this
tyrosine kinase develop osteopetrosis in the face of ade-
quate numbers of dysfunctional OCs (Soriano et al.,
1991). The fact that c-Src
 
 
 
/
 
 
 
 OCs fail to organize a normal
cytoskeleton suggests that c-Src may be a signaling mole-
cule that associates with, and is activated by, 
 
 
 
v
 
 
 
3 (Duong
et al., 2000; Sanjay et al., 2001). In addition, c-Cbl, a sub-
strate of c-Src in OCs, is recruited to adhesion sites where
it modulates the binding of the vitronectin (VN) receptor
 
 
 
v
 
 
 
3 (Sanjay et al., 2001). Pyk-2, a member of the FAK
family of kinases, is a signaling molecule that binds c-Src
and c-Cbl, and appears to be essential for bone resorption.
Pyk2 is activated when OCs are plated on ligands recog-
nized by 
 
 
 
v
 
 
 
3 and is important for cytoskeletal organiza-
tion during OC adhesion, migration, and sealing zone for-
mation (Duong et al., 1998). The above compendium of
events suggests that Pyk2 activation, in osteoclastic resorp-
tion, is mediated by 
 
 
 
v
 
 
 
3.
Rho family GTP-ases control cytoskeletal organization
and dynamics and integrin-mediated signaling, as their inhi-
bition blocks 
 
 
 
v
 
 
 
3-dependent motility (Clark et al., 1998;
Ridley et al., 1999; Chellaiah et al., 2000; Ory et al., 2000).
Importantly, Rho and Rac regulate the OC actin ring, and
their blockade blunts the resorptive activity of the cell (Raz-
zouk et al., 1999; Ory et al., 2000).
In the present study, we establish that the 
 
 
 
3 cytoplasmic
domain, specifically S
 
752
 
, is responsible for organizing the
OC cytoskeleton. Furthermore, like adhesion-dependent cy-
toskeletal reorganization, growth factor–induced 
 
 
 
v
 
 
 
3 in-
side-out signaling activates Rho GTPases. Finally, although
 
 
 
v
 
 
 
3 is essential for activation of c-Src and c-Cbl, OCs
lacking the integrin fully activate Pyk2.
 
Results
 
A functional 
 
 
 
3 integrin cytoplasmic domain is 
required for its association with the actin cytoskeleton
 
Mice deleted of the 
 
 
 
3 integrin subunit become osteoscle-
rotic due to dysfunctional OCs, which fail to efficiently re-
sorb bone (McHugh et al., 2000). As expected, the func-
tion of 
 
 
 
3
 
 
 
/
 
 
 
 OCs is rescued by transduction with
retrovirus expressing full-length 
 
 
 
3 cDNA. On the other
hand, 
 
 
 
3 lacking its cytoplasmic domain, or carrying a
S
 
752
 
P mutation, is incapable of rescuing OCs devoid of en-
dogenous 
 
 
 
3 (Feng et al., 2001). Furthermore 
 
 
 
3
 
 
 
/
 
 
 
 OC
precursors cultured with RANKL and standard doses of
M-CSF fail to differentiate fully (Faccio et al., 2003). This os-
teoclastogenic defect can be rescued by increasing M-CSF
concentrations, but the ability of these cells to resorb bone
requires the presence of the integrin (Faccio et al., 2003).
To further define the role that the 
 
 
 
3 integrin cytoplasmic
domain plays in organizing the OC cytoskeleton, we stud-
ied the distribution of podosomes in 
 
 
 
3
 
 
 
/
 
 
 
 OCs trans-
duced with different human 
 
 
 
3 integrin mutants. Four
constructs were used for this purpose: the 
 
 
 
3 integrin lack-
ing its cytoplasmic tail (
 
 
 
3-
 
 
 
C); a mutant carrying the
S
 
752
 
P mutation or that bearing the OC nonsignificant dou-
ble tyrosine mutation, Y
 
747
 
F/Y
 
759
 
F; and as positive control,
the full-length human 
 
 
 
3 (
 
 
 
3 WT). Equivalent levels of
expression of all four constructs were confirmed by flow cy-
tometry and by Western blot analysis (Fig. 1, A and B).
Bone marrow macrophages (BMMs) expressing the indi-
cated mutants were cultured on coverslips in the presence
of RANKL (100 ng/ml) and a high dose of M-CSF (100
ng/ml), conditions that lead to the formation of completely
spread OCs, even in nontransduced 
 
 
 
3
 
 
 
/
 
 
 
 cultures (Faccio
et al., 2003). These cells cultured in high M-CSF are
equivalent to their WT counterparts in terms of morphol-
ogy, osteoclastogenic markers (Faccio et al., 2003), c-Fms
(the receptor for M-CSF) levels, and pattern of integrin ex-
pression (see Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200212082/DC1).
To delineate actin organization, OCs expressing the vari-
ous mutants were immunostained with the anti–human 
 
 
 
3
mAb 1A2 and costained with FITC–phalloidin (Fig. 2 A).
The 
 
 
 
3 integrin is organized in rosette-like structures, sur-
rounding a core of F-actin bundles, in podosomes as previ-
ously described (Faccio et al., 2002). In nonresorbing OCs
on glass, podosomes accumulate at high density at the pe-
riphery, yielding a row of actin dots flanked on each side by
 
 
 
3 integrin bands. This organization is present in 
 
 
 
3
 
 
 
/
 
 
 
OCs bearing 
 
 
 
3 WT or the 
 
 
 
3 Y
 
747
 
F/Y
 
759
 
F mutation. Lack
of functional 
 
 
 
3, as in 
 
 
 
3-
 
 
 
C and 
 
 
 
3 S
 
752
 
P mutants, com-
pletely abrogates the distribution of the integrin around the
peripheral ring of F-actin, despite the normal appearance of
Figure 1. Expression levels of  3 mutants by flow cytometry and 
Western blot. (A) BMMs expressing h 3 WT, h 3- C, h 3 S
752P, or 
h 3 Y
747F/Y
759F were incubated with a mAb against  3 integrin 
(1A2), followed by FITC-conjugated secondary antibody (solid 
lines). Cells with secondary antibody alone were used as negative 
control (dotted lines). (B) Mature OCs expressing the indicated  3 
mutants were subjected to Western blot analysis using 7G2, a mAb 
against h 3. Equal loading was confirmed by actin.T
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the actin cytoskeleton. Similar results were obtained with
another anti–human  3 mAb, AP3 (unpublished data). In-
terestingly other cytoskeletal components, including talin
and vinculin, remain normally distributed in the podosomes
of all mutants (see Fig. S2, available at http://www.jcb.org/
cgi/content/full/jcb.200212082/DC1).
To determine if the observations made on nonresorbing
OCs are replicated in resorbing cells, the four species of  3-
transduced OCs were generated on whale dentin and stained
for the integrin and actin. Confocal microscopy reveals that
the integrin, in dentin-resorbing  3 WT– and  3 Y
747F/
Y
759F–expressing cells, localizes with the actin ring (Fig. 2
B). Once again, the  3- C and  3 S
752P mutants are dif-
fusely distributed throughout the cell. This diffuse localiza-
tion is not due to an increase in internalization, as the flow
cytometric analysis shows similar surface expression levels to
 3 WT and  3 Y
747F/Y
759F mutants (Fig. 1 A).
External conformation of  3 integrin does not depend 
on the cytoplasmic domain
One possible explanation for the failure of  3- C and  3
S
752P to localize to podosomes is that the external domain of
these mutants is not able to assume the activated, high-affin-
ity conformation necessary for appropriate substrate interac-
tion. One tool to assess the ability of  3 integrin to assume
the activated conformation of the external domain is the anti–
ligand-induced binding site (LIBS) antibody AP5. In low cal-
cium buffer, this Ab binds all  v 3 integrin on the cell
surface, converting it to the active conformation. In high cal-
cium buffer, AP5 binds only the integrin already in the
activated state (Faccio et al., 2002). An increase in fluores-
cence intensity of  v 3-expressing cells when AP5 binding is
assessed in low calcium, relative to high calcium buffer, indi-
cates that the external domain of the integrin can assume the
activated conformation in response to the Ab. When pre-OCs
transduced with  3- C and  3 S
752P, as well as with  3 WT
and  3 Y
747F/Y
759F, are analyzed in this manner, there is an
increase in AP5 binding in low calcium, indicating that each
of these  3 constructs undergoes conformational change (Fig.
3 A). Thus, the failure of the  3- C and  3 S
752P mutants to
properly localize in podosomes does not reflect an inability of
these integrins to assume an activated conformation.
Growth factor–mediated inside-out activation of  3 is 
dependent on its cytoplasmic domain
A second possible explanation for the aberrant localization of
 3- C and  3 S
752P pre-OCs is that these mutants are not
activated by signals emanating from the cell interior. One
mechanism for such inside-out activation is growth factor
treatment. We have previously shown that both HGF and
M-CSF activate  v 3 in this manner (Faccio et al., 2002).
To determine whether the  3- C and  3 S
752P mutants are
defective in growth factor–mediated activation, pre-OCs trans-
duced with the  3 mutants were incubated with either HGF
or M-CSF for 30 min before evaluation of the activated state
of the integrin via AP5 staining in high calcium buffer. HGF
and M-CSF activate  3 WT and  3 Y
747F/Y
759F, but fail to
impact the integrin lacking the entire cytoplasmic domain
( 3- C) or bearing S
752P (Fig. 3 B). Thus, the  3 cytoplas-
mic domain, and specifically S
752, is required for growth fac-
tor–induced formation of a high-affinity  v 3 complex.
Localization of activated  v 3 integrin to lamellipodia 
requires the  3 cytoplasmic domain
Upon growth factor activation, OC  v 3 moves to the mo-
tile region of the cell membrane (Faccio et al., 2002). Having
found that dysfunctional  3 mutants fail to properly localize
in resting OCs, and do not become activated in response to
growth factors, we determined if these mutants also fail to lo-
calize properly in the newly formed lamellipodia in response
to growth factor stimulation. Thus,  3
 /  OCs bearing WT
 3,  3- C,  3 Y
747F/Y
759F, or  3 S
752P constructs grown on
coverslips were exposed to HGF or M-CSF for 30 min and,
after fixation, stained with AP5 (in high calcium) to detect
localization of the activated form of  v 3. Unstimulated
OCs carrying  3 WT or the Y
747F/Y
759F mutation express
Figure 2. S
752 in the  3 cytoplasmic 
domain regulates integrin localization. 
Mature  3
 /  OCs transduced with the 
indicated  3 mutants were generated in the 
presence of RANKL and high dose M-CSF 
on glass coverslips (A) or dentin (B). Cells 
were stained with an anti–human  3 mAb 
(1A2) (red) and with FITC–phalloidin to detect 
actin distribution (green) and analyzed by 
confocal microscopy. Merged pseudocolored 
images obtained from the same confocal 
plane show the colocalization of  3 and 
F-actin in yellow. (A) OCs on coverslips 
bearing h 3 WT or h 3 Y
747F/Y
759F organize 
 v 3 (a and j) in a donut-like structure, 
around the F-actin core (b and k) of podo-
somes (merged on c and l).  3- C (d and e) 
or the S
752P mutation (g and h) fail to organize 
around the F-actin core, but are diffuse on 
the cell surface (merged on f and i). (B)  3 
WT or  3 Y
747F/Y
759F integrin (a and j) and actin (b and k) in OCs grown on dentin form well-defined, colocalizing rings (merged on c and l). 
In contrast, in  3- C or  3 S
752P mutants, the integrin (d and g) is diffusely distributed and fails to localize with the actin ring (e and h, 
merged in f and i). Bars, 5  m.T
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the activated integrin along membrane ruffles and in lamelli-
podia (Fig. 4 A, CTR). Treatment with either growth factor
induces AP5-positive membrane extensions (lamellipodia).
This phenomenon is completely abrogated in  3- C– and
 3 S
752P–bearing cells, which are unable to spread and form
lamellipodia in response to growth factors (Fig. 4 A). These
observations are confirmed by counting the percentage of
cells with multiple lamellipodia extensions (Table I). These
data show that M-CSF and HGF induce lamellipodia in cells
expressing   3 WT and  3 Y
747F/Y
759F but not in those
transduced with  3- C or  3 S
752P.
We next turned to the effect of HGF or M-CSF on den-
tin-residing OCs, which represent resorptive cells. OCs ex-
pressing  3 WT or  3- C were exposed to the individual
cytokines and stained with AP5 (Fig. 4 B). In  3 WT–bear-
ing cells, this exercise revealed that both cytokines induce
membrane protrusions (arrows) that contain a predomi-
nance of activated  v 3. Despite their ability to attach to
bone and form actin rings on dentin,  3- C OCs are unaf-
fected by the growth factors, failing to spread and lacking
membrane protrusions. Note that the activated integrin is
Figure 3.  3 S
752 regulates inside-out, but not outside-in, activation 
of  v 3. (A)  3
 /  pre-OCs expressing the indicated mutants were 
incubated with AP5 (50  g/ml) in low or high calcium and subjected to 
FACS
® analysis. Results are presented as overlapping histograms for 
high (white) and low (gray) calcium treatments for each mutant. The 
tracings for high calcium buffer indicate basal activation of the integrin, 
as in this circumstance, AP5 binds previously activated  v 3 integrin. 
A shift toward higher fluorescence intensity in low calcium buffer 
indicates that AP5 mediates integrin activation. In each group of 
transduced pre-OCs, incubation with AP5 in low calcium buffer 
yields a significant increase in mean fluorescence intensity, relative 
to high calcium buffer, indicating that activation by this anti-LIBS 
Ab from the cell’s exterior does not depend on the  3 cytoplasmic 
domain. (B) Pre-OCs were preincubated with HGF (50 ng/ml, light 
gray bars) or M-CSF (100 ng/ml, dark gray bars) before staining with 
AP5 in high calcium buffer to determine the degree of growth factor–
mediated integrin activation. Results are expressed as fold increase 
in the mean fluorescence intensity of AP5 staining compared with 
unstimulated control cells (CTR), arbitrarily designated as 1 for each 
untreated mutant.
Figure 4. Localization of  v 3 in lamellipodia and membrane 
extensions is regulated by functional  3 cytoplasmic domain. 
(A) Mature  3
 /  OCs expressing the indicated  3 integrin constructs 
were either untreated (CTR) or stimulated with M-CSF or HGF to 
induce integrin activation, and stained with mAb AP5 (red), which 
detects only activated integrin. In control circumstances, cells 
expressing  3 WT (a) and  3 Y
747F/Y
759F (j) present the activated 
integrin in lamellipodia (arrows). In contrast, in OCs expressing  3- C 
(d) and  3 S
752P (g), the activated integrin is randomly distributed 
throughout the cytoplasm. M-CSF or HGF clusters activated  3 WT 
(b and c, arrows) and  3 Y
747F/Y
759F (k and l arrows) at the cell’s 
edge, while  3- C (e and f) and  3S
752P (h and i) remain diffusely 
distributed. (B)  3
 /  OCs expressing h 3 WT or h 3- C cultured 
on dentin were stained with AP5 (red) and FITC–phalloidin (green). 
Shown are pseudocolored overlay images taken in the same 
confocal plane.  3 WT OCs stimulated with HGF or M-CSF form 
AP5-containing membrane extensions (arrows). In contrast, OCs 
expressing  3- C show no response to the cytokines, despite their 
ability to form an actin ring. Bars, 10  m.T
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only weakly localized in the actin ring, in all mutants, as pre-
viously described (Faccio et al., 2002, 2003).
Growth factors promote cytoskeletal rearrangement in 
a  3 integrin–dependent manner
The observation detailed in Fig. 4 led us to hypothesize that
the   3 integrin controls cytoskeletal changes induced by
growth factors. To address this issue, we stained unstimu-
lated and growth factor–treated  3
 /  and  3
 /  OCs with
FITC–phalloidin and analyzed actin organization by confo-
cal microscopy. Once again, the absence of  3 integrin does
not alter the peripheral podosomal distribution of F-actin in
untreated OCs (Fig. 5 A, CTR). However, in the presence of
HGF or M-CSF, F-actin moves from the podosomes to short
filamentous protrusions, consistent with lamellipodia forma-
tion, only in  3
 /  OCs (Fig. 5 A, low and high magnifica-
tion; Table I). To confirm that this observation is an inte-
grin-dependent consequence of podosome reorganization, we
examined the distribution of  -actinin, a cytoskeletal protein
involved in the formation and stability of podosomes, and
a link between actin and integrins (Pavalko et al., 1991).
 -Actinin distribution in  3
 /  and  3
 /  OCs mirrors that
of actin, both in the presence and absence of growth factors
(Fig. 5 A). Consistent with this finding, immunoblot analysis
shows an increase in the pool of  -actinin present in the Tri-
ton X-100 soluble fraction exclusively in  3
 /  OCs treated
with HGF and M-CSF (Fig. 5 B). In  3
 /  cells,  -actinin
remains in the insoluble fraction. Similar results were ob-
tained using OCs transduced with the different  3 mutants.
Dramatic changes in the peripheral ring of actin are seen in
response to M-CSF (Fig. 5 C), and the content of  -actinin
in the Triton X-100 soluble fraction increases in  3 WT and
Table I. Lamellipodia formation in response to M-CSF and HGF is 
regulated by functional  3 cytoplasmic domain
 3 constructs CTR  HGF  M-CSF
WT 34   5 73   4
a 70   6
a
 C 13   7 25   10 20   10
S
752P 10   5 14   5 15   6
Y
747F/Y
759F 20   4 74   8
a 60   5
a
OCs bearing the indicated  3 constructs were cultured on coverslips,
treated with M-CSF or HGF for 30 min, fixed, and stained with FITC–
phalloidin to detect the actin organization. Ten 200  fields per coverslip
were analyzed in triplicate. Data represent the percentage of cells with
multiple lamellipodia extensions. M-CSF and HGF induce lamellipodia in
cells expressing  3 WT and  3 Y747F/Y759F but not in those transduced
with  C 3 or  3 S752P.
aP   0.001 vs. CTR.
Figure 5. HGF- and M-CSF–induced 
cytoskeletal reorganization is  v 3 
dependent. (A)  3
 /  or  3
 /  OCs, cultured 
on coverslips, were treated with 100 ng/ml 
M-CSF or 50 ng/ml HGF for 10 min. Cells 
were stained with FITC–phalloidin for 
actin (green) and anti– -actinin mAb (red). 
Although the absence of  v 3 does not alter 
the peripheral ring of actin in untreated cells 
(CTR), redistribution of podosomes, along 
with  -actinin, into membrane extensions in 
response to growth factors is observed only 
in  3
 /  OCs (pseudocolor overlays). High 
magnification images of the peripheral 
membrane (center) show the reorganization 
of actin (ACT) and  -actinin ( -Act) from 
podosomes to membrane ruffles in  3
 /  
but not in  3
 /  OCs. Bar, 10  m. (B)  3
 /  
or  3
 /  OCs, treated as in A, were lysed 
in a Triton X-100 buffer, and soluble and 
insoluble fractions were separated by 
centrifugation. Immunoblot analysis was 
used to detect the distribution of  -actinin 
in the two fractions. (C)  3
 /  OCs transduced 
with the indicated mutants were treated 
with M-CSF (A) stained for actin (green) or 
 -actinin (red). Overlay high magnification 
images show a redistribution of podosomes 
into newly formed membrane extensions 
only in  3 WT and  3 Y
747F/Y
759F mutants. 
(D) Transduced OCs, treated as in C were 
lysed in a Triton X-100 buffer, and  -actinin 
distribution in the soluble fraction was 
analyzed by Western blot. (E) Immunolocal-
ization of c-Fms in mature OCs expressing 
the indicated  3 mutants. Cells were stained 
for c-Fms (green) and costained with TRITC–
phalloidin for actin (red). Overlays show 
similar distribution of c-Fms in all  3 mutants. 
Bar, 10  m.T
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 3 Y
747F/Y
759F mutants, but not in those transduced with
 3- C or  3 S
752P (Fig. 5 D). The failure of  3-null cells to
respond to M-CSF is not dependent on different expression
levels of c-Fms (Fig. S1) or on its different localization
among the various  3 mutants (Fig. 5 E). These observations
suggest that, in OCs, growth factor–induced reorganization
of podosomes, leading to the formation of new membrane
ruffles, is a  3-dependent event.
 3 integrin cytoplasmic domain governs OC adhesion 
and migration
The fact that  3- C– and  3 S
752P–expressing OCs fail to
spread in response to growth factors suggests that interaction
of these mutant integrins with the extracellular matrix may
be defective. To address this issue, we plated  3
 /  pre-OCs
bearing the various constructs on osteopontin (OPN), a sub-
strate recognized by the  v 3 integrin, or, as negative con-
trol, on BSA. Pre-OC adhesion to OPN is decreased three-
fold in cells carrying the  3- C or S
752P mutations,
compared with  3 WT pre-OCs (Fig. 6 A), mirroring the
defective adhesion of  3
 /  cells (unpublished data). Fur-
thermore, pretreatment with AP5, HGF, or M-CSF, all of
which activate the integrin (Fig. 3), enhances the number of
adherent   3 WT by 40–50%, and to a lesser extent  3
Y
747F/Y
759F–expressing cells (Fig. 6 A). On the other hand,
these integrin-activating agents fail to impact the adhesion
of  3- C– and  3 S
752P–bearing pre-OCs. Similar results
were obtained using VN as a substrate (unpublished data).
In contrast, adhesion to native collagen, a  3 integrin–inde-
pendent substrate, was similar in all mutants and was not
enhanced by growth factors (unpublished data).
As substrate recognition initiates lamellipodia extension
and directed cell movement, we next assessed the migration
of pre-OCs transduced with the various  3 constructs, using
a transwell assay in which the lower surface of the membrane
was coated with OPN (Fig. 6 B). Pre-OC migration toward
OPN is impaired in the absence of the  3 cytoplasmic do-
main or with the S
752P mutation, mimicking the behavior of
 3
 /  cells (unpublished data). Moreover, AP5, HGF, and
M-CSF all fail to enhance the directed mobility of  3- C
and S
752P mutant cells. Once again, similar results were gen-
erated using VN as substrate (unpublished data). Thus,
these data mirror the defective growth factor–induced inte-
grin activation of  3- C and S
752P mutants (Fig. 3 B).
Rho family GTPase activation is impaired in  3
 /  OCs
Numerous signal transduction molecules, including Rho
GTPases, associate with integrin complexes in adherent cells
Figure 6. Pre-OC adhesion and migration require functional  3 
cytoplasmic domain. (A) Adhesion assays to OPN were performed 
using  3
 /  pre-OCs bearing the indicated  3 constructs. Adhesion 
to OPN is decreased threefold in cells carrying  3- C or  3 S
752P 
(CTR bars, dark gray) and is not affected by AP5 (light gray), HGF 
(black), or M-CSF (gray), which induce integrin activation. In contrast, 
the same factors increased adhesion of  3 WT– and  3 Y
747F/Y
759F–
expressing cells by 40–50%. (B) Migration assay toward OPN was 
performed on the same cells as in A. Migration of untreated cells 
toward OPN (CTR, dark gray) is impaired in  3- C and  3 S
752P 
mutants. Moreover, AP5 (light gray), HGF (black), and M-CSF (gray) 
fail to rescue the directed mobility of these cells, whereas the same 
factors enhance the migratory capacity of  3 WT– and  3 Y
747F/Y
759F–
expressing cells. *, P   0.01 vs. CTR; **, P   0.05 vs. CTR.
Figure 7. Growth factor activation of Rho GTPases requires 
functional  3 cytoplasmic domain. (A) OCs were exposed to HGF 
or M-CSF for 15 min, and Rho activation was assessed by pull-down 
binding assay.  3
 /  OCs respond to both growth factors with a 
sixfold increase in GTP-bound Rho, whereas  3
 /  OCs do not 
respond to either growth factor. Immunoblot for total Rho in cell 
lysates is shown below. (B)  3
 /  and  3
 /  cells were stimulated 
with M-CSF for the indicated times, and Rac activation was assessed 
by pull-down binding assay. As a loading control, a fraction of the 
cell lysates was immunoblotted with the Rac mAb. Rac activation 
occurs only in  3
 /  OCs, in a biphasic manner. (C) The experiment 
described in A was repeated with  3
 /  OCs transfected with the 
indicated  3 constructs. Whereas  3 WT– and  3 Y
747F/Y
759F–bearing 
OCs respond like their  3
 /  counterparts, no such induction occurs 
in those expressing  3- C or S
752P.T
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and regulate adhesion-dependent morphological changes
(Pavalko et al., 1991; Yamada and Miyamoto, 1995; Clark
et al., 1998). Furthermore, distinct aspects of adhesion and
migration are controlled by different Rho family members.
For example, Rho, Rac, and Cdc42, respectively, regulate
the formation of stress fibers, lamellipodia, and filopodia. As
 3
 /  OCs exhibit defective adhesion, spreading, and cyto-
skeletal rearrangement in response to growth factors, we
asked if these phenomena reflect impaired activation of Rho
GTPases. To this end,  3
 /  and  3
 /  OCs were exposed
to HGF or M-CSF, and Rho and Rac activation were as-
sessed by pull-down binding assays. Mirroring the cytoskele-
tal defects, Rho activation in response to both growth factors
is completely arrested in  3
 /  OCs, compared with the six-
fold increase seen in  3
 /  OCs (Fig. 7 A). Similarly,
whereas Rac is activated in a biphasic manner in  3
 /  OCs
exposed to M-CSF, no such activation occurs in  3
 /  OCs
(Fig. 7 B). To determine if integrin-mediated Rho activation
is dependent on an intact  3 cytoplasmic domain, we re-
peated these experiments with  3
 /  OCs transduced with
the various  3 constructs. Whereas  3 WT– and  3 Y
747F/
Y
759F–expressing OCs respond to growth factor with an in-
crease in GTP-bound Rho, no induction occurs in those ex-
pressing  3- C or  3 S
752P (Fig. 7 C).
Phosphorylation of c-Src and c-Cbl, but not Pyk2, 
is impaired in  3
 /  OCs
The data presented thus far establish that the  3 integrin
plays an essential role in OC cytoskeletal function, a process
mediated at least in part by Rho family GTPases. These ob-
servations prompted us to examine the more proximal events
thought to mediate  v 3 signal transduction. Pyk2, believed
to be central to the mechanisms by which OCs resorb bone,
is activated when these cells interact with  v 3 ligands
(Duong et al., 2000; Sanjay et al., 2001). Surprisingly, how-
ever, Pyk2 activation, as manifest by its phosphorylation, is
indistinguishable in  3
 /  and  3
 /  pre-OCs plated on VN
for 30 and 60 min (Fig. 8 A, top). In contrast, c-Src phos-
phorylation occurs in a  3-dependent manner, and c-Cbl
phosphorylation is markedly reduced in the absence of the
integrin (Fig. 8 A). In keeping with this observation, Pyk2
and c-Src coprecipitate in VN-adherent  3
 /  cells but not
those lacking the  3 integrin (Fig. 8 B). Furthermore,  3
 / 
pre-OCs expressing all  3 constructs show phosphorylation
of Pyk2 upon adhesion, whereas c-Src and c-Cbl activation is
defective in  3- C and S
752P (Fig. 8 C). Pfaff and Jurdic
(2001) have recently shown direct interaction of both Pyk2
and paxillin, a structural component of podosomes, with the
COOH-terminal region of the integrin  3 tail. Interestingly,
we find that binding of Pyk2 to paxillin is identical in all  3
mutants, but its ability to bind the  3 receptor itself is de-
pendent on an intact cytoplasmic tail and S
752 (Fig. 8 D).
Our data show that Pyk2 activation requires cell–matrix
recognition but does not depend upon  v 3 status. Previous
studies have shown that Pyk2 phosphorylation is calcium de-
pendent (Sanjay et al., 2001), and we find that in  3
 /  and
 3
 /  pre-OCs, the intracellular chelator, BAPTA, elimi-
nates Pyk2 activation (Fig. 9 A). To determine if another
OPN receptor or integrin might be responsible for Pyk2
phosphorylation, we assessed this parameter in cells deleted
of CD44, which has been shown to mediate monocyte at-
tachment to OPN (Weber et al., 1996), or in cells lacking the
integrin  2 1, another adhesive receptor expressed on OCs
(unpublished data). Attachment to OPN leads to Pyk2 phos-
phorylation and to an increase in its association with paxillin
in all cells tested (Fig. 9 B). To find the receptor mediating
Pyk2 phosphorylation in response to cell adhesion, we turned
to the  2 integrin, which is expressed in pre-OCs (Fig. S1)
and is known to be a plastic receptor (Hirano et al., 2002).
Thus,  3
 / ,  3
 / , and  2
 /  pre-OCs were maintained in
Figure 8. c-Src and c-Cbl, but not Pyk2, activation is 
impaired in  3
 /  OCs. (A) Serum-starved pre-OCs were 
lifted and maintained in suspension (S) or replated on VN 
for 30 or 60 min. Equal amounts of proteins were immuno-
precipitated with anti-Pyk2 mAb followed by immunoblot 
with antiphosphotyrosine mAb 4G10. Aliquots of the 
same lysate were immunoprecipitated with an antiphos-
photyrosine mAb (PY99) followed by c-Src or c-Cbl 
immunoblot. Pyk2 phosphorylation, although not 
occurring in suspended cells, is indistinguishable in  3
 /  
and  3
 /  pre-OCs plated onto VN. In contrast, c-Cbl and 
c-Src phosphorylation occurs in a  3-dependent manner. 
(B) Lysates from  3
 /  or  3
 /  pre-OCs, adherent with 
time on VN (30 or 60 min), were subjected to Pyk2 
immunoprecipitation followed by c-Src or antiphospho-
tyrosine (PY99) immunoblot. In the absence of the  3 
integrin, Pyk2 does not associate with c-Src. (C)  3
 /  
pre-OCs expressing the indicated  3 mutants were 
maintained in suspension (S) or were adherent (A) on VN 
for 30 min. Immunoprecipitation of lysates with antiphos-
photyrosine (PY99) preceded immunoblot analysis of Pyk2, 
c-Cbl, and phospho-Src (Y416).  -Actin is the loading 
control. c-Src and c-Cbl phosphorylation are arrested in 
cells expressing  3- C or  3 S
752 P, but not  3 WT or  3 Y
747F/Y
759F. In all circumstances, Pyk2 phosphorylation remains intact. (D) Adherent 
OCs expressing the indicated  3 mutants were lysed, immunoprecipitated with Pyk2, and immunoblotted for  3 and paxillin. Association of 
Pyk2 with  3, but not with paxillin, requires intact  3 cytoplasmic tail and Ser
752. Immunoblot for  3 shows similar expression level of the 
integrin in all mutant cells.T
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suspension or plated on VN or uncoated plastic for 30 min
(Fig. 9 C). Plastic, like VN, induces Pyk2 phosphorylation in
wild-type pre-OCs and those lacking  v 3. However, Pyk2
phosphorylation of  2
 /  pre-OCs is completely abrogated
when these mutant cells are plated on plastic and is barely de-
tectable on VN, an observation that does not reflect dimin-
ished  3 integrin expression (Fig. 9 D). Furthermore, these
findings do not result from altered Pyk2 levels in  2
 /  OCs
(Fig. 9 C) or differing distribution (unpublished data). Thus,
 2 integrin, but not  3 integrin or CD44, mediates Pyk2 ac-
tivation in pre-OCs.
Discussion
Marrow macrophages derived from  3
 /  mice, placed in
standard osteoclastogenic conditions, fail to become fully
differentiated OCs and resorb mineralized matrix poorly
(Faccio et al., 2003). On the other hand, culture of these
cells in high concentrations of M-CSF, as undertaken in this
work, completely rescues the differentiation of these inte-
grin-deficient OCs as manifest by their histological appear-
ance and expression of osteoclastogenic markers. It is sur-
prising, therefore, that despite the normal appearance in
high dose M-CSF,  3
 /  OCs remain defective resorbers.
To define the mechanisms responsible for the continued
failure of  3
 /  OCs, generated in high M-CSF, to resorb
bone, we analyzed the differences in cytoskeletal organiza-
tion and relevant intracellular signaling molecules in OCs
with and without functional  3 integrins.
 v 3, in OCs, exists in two conformational states, which
are differentially distributed on the cell surface (Faccio et al.,
2002). In its basal condition, the receptor localizes in the
sealing zone and podosomes, while the activated integrin is
principally associated with motile areas of the membrane.
The extracellular components of  v 3 modulating its acti-
vation state are in hand (Beglova et al., 2002), and those in
the cytoplasmic domain, which respond to growth factor
stimulation and thus mediate inside-out signaling, have been
partially identified (Takagi et al., 2002; Vinogradova et al.,
2002). To further address this issue, we turned to a system
of retroviral transduction, which previously permitted us to
express various human  3 integrin mutants in OCs and
their precursors (Feng et al., 2001).
Our first exercise established that the  3 cytoplasmic do-
main is essential for appropriate distribution of the integrin
to cytoskeletal structures such as podosomes and lamellipo-
dia. Mirroring their effect on OC spreading and matrix re-
sorption,  3 mutants, lacking the cytoplasmic domain or
bearing S
752P, distribute abnormally in OCs residing on
glass and dentin, failing to colocalize with F-actin. This ob-
servation prompted us to ask if the same components of the
 3 integrin are involved in modulating the conformational
state of the intact heterodimer.
Antibodies recognizing the activated conformation bind
the LIBS in the NH2 terminus of integrin heterodimers
(Bodeau et al., 2001). In high calcium buffer, the anti-LIBS
mAb AP5 recognizes activated, high-affinity ligand-binding
 v 3 integrin. Importantly, in low calcium buffer, AP5
binds to all  v 3 and forces all receptors into the activated
conformation. This AP5-induced conformational change of
 v 3 involves a direct effect on the external domain of the
integrin and does not require the  3 cytoplasmic domain.
On the other hand, the heterodimer’s biological activity re-
quires the cytoplasmic tail. Thus,  3
 /  OCs bearing  3-
 C or  3 S
752P have decreased adhesive and migratory capa-
bilities, suggesting defective outside-in signaling. In contrast
to the direct effect of AP5 in changing the external confor-
mation of  3, HGF and M-CSF modulate adhesion and
spreading of mature OCs by activating the  v 3 integrin via
the  3 cytoplasmic domain by inside-out signaling (Insogna
et al., 1997; Teti et al., 1998; Faccio et al., 2002).
Active OCs form a stable ring of actin, which delineates
the ruffled membrane where the resorptive process takes
place. Our previous observations, showing abnormal actin
rings in  3-null OCs generated in low dose M-CSF, indi-
cate that  3 contributes to the formation of this structure.
Figure 9. Pyk2 activation in pre-OCs is dependent upon intracellular 
calcium and  2 integrin. (A)  3
 /  and  3
 /  pre-OCs were 
preincubated with the calcium chelator BAPTA before plating on 
VN for 30 min. Cells were lysed and analyzed by Western blot for 
total Pyk2 and its Y
402-phosphorylated species. BAPTA inhibits Pyk2 
phosphorylation in both cell types. (B)  3
 / ,  3
 / , and CD44
 /  
pre-OCs were lifted or replated onto OPN for 30 min, and lysates 
were immunoprecipitated for Pyk2 and analyzed by Western blot 
for phosphotyrosine (4G10) and paxillin. Cell adhesion leads to 
Pyk2 phosphorylation and increase in association with paxillin in all 
cells tested. (C)  3
 / ,  3
 / , and  2
 /  pre-OCs were maintained in 
suspension or plated on VN or plastic (PL) for 30 min. Adhesion on 
both VN and plastic induced Pyk2
Y402 phosphorylation in  3
 /  and 
 3
 /  pre-OCs. In contrast, Pyk2 phosphorylation on either VN or 
plastic is completely abrogated in cells lacking the  2
 /  integrin. 
(D) RT-PCR for  3 integrin in  2
 /  and  2
 /  pre-OCs cultured for 
1, 2, and 3 d with RANKL and M-CSF.T
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We have also found that  v 3 and M-CSF cooperate dur-
ing osteoclastogenesis (Faccio et al., 2003). In this study, we
find that  3
 /  OCs, or those expressing the human muta-
tion S
752P, exhibit normal actin distribution when generated
in high dose M-CSF, indicating that M-CSF can compen-
sate for lack of  v 3 in actin ring formation.
Podosomes, found in adherent OCs, are rosette-like struc-
tures containing  v 3 around an actin core (Marchisio et
al., 1988). In contrast to the relatively static actin ring, po-
dosomes are dynamic, rapidly redistributing under the influ-
ence of extracellular stimuli such as HGF and M-CSF (In-
sogna et al., 1997; Teti et al., 1998; Faccio et al., 2002). Here
we show that  3 integrin is absolutely required for dynamic
changes in the actin cytoskeleton in response to growth fac-
tors or cell attachment.  3- C or  3 S
752P mutants fail to
form lamellipodia when plated on glass (Fig. 4 A) or on den-
tin (Fig. 4 B). In agreement with these observations,  -acti-
nin, which links actin filaments directly to integrin receptors
(Pavalko et al., 1991; Otey et al., 1993), fails to enter the
Triton X-100 soluble fraction of  3
 /  pre-Ocs, or  3- C
and   3 S
752P mutants, in response to growth factors. In
other cell types, redistribution of  -actinin, from focal adhe-
sions to the Triton X-100 soluble fraction, is associated with
loss of close apposition of cell membrane to the extracellular
matrix, consistent with enhanced motility (Greenwood et
al., 2000).
Modulation of the OC cytoskeleton is controlled by Rho
GTPases. For example, dominant negative Rho arrests po-
dosome organization, OC motility, and bone resorption
(Chellaiah et al., 2000), and Rac inhibition decreases the re-
sorptive activity of OCs (Razzouk et al., 1999). The mecha-
nisms of Rho and Rac activation in OCs are poorly defined.
We find that the defect in migration and lamellipodia for-
mation in  3 S
752P OCs, in response to growth factors, is as-
sociated with failure to activate Rho and Rac.
Interestingly, OCs bearing  3 Y
747F/Y
759F are indistin-
guishable from wild-type cells in their appearance and re-
sorptive capabilities, but adhesiveness to OPN is moderately
decreased. Recently, phosphorylation levels of the  3 Y747
and 759 have been correlated with strength of binding dur-
ing adhesion (Boettiger et al., 2001). It is possible that in
OCs, these tyrosines are required for stable and strong adhe-
sion, but not for efficient migration. As motility is requisite
for bone resorption, the Y
747F/Y
759F mutation does not
compromise the physiological function of these cells.
The ability of M-CSF to induce OC spreading and actin
reorganization depends on c-Src expression (Insogna et al.,
1997). Sanjay et al. (2001) have shown that upon adhesion,
 v 3 forms a complex with Pyk2 and c-Src that, in turn, re-
cruits c-Cbl, resulting in podosome assembly. This model
holds that c-Cbl binds to Tyr 
416 in the c-Src kinase domain,
which down-regulates both Src kinase activity and integrin-
mediated adhesion, prompting podosome detachment and
subsequent disassembly. Consistent with this hypothesis, we
find that activation of c-Src and c-Cbl, in response to VN
adherence, is abrogated in  3
 /  OCs and in  3- C and  3
S
752P mutants, thereby decreasing podosome turnover and,
consequently, OC adhesion and migration.
Our data, however, stand in contrast to the conclusions of
Sanjay et al. (2001) and Nakamura et al. (2001), who claim
that  v 3 is essential for Pyk2 phosphorylation. We believe
this discrepancy may reflect the fact that we directly assessed
Pyk2 phosphorylation in authentic pre-OCs, deleted of the
 v 3 receptor. Two possibilities present themselves as to
how OCs lacking  v 3 phosphorylate Pyk-2. First, Pyk2
activation is calcium dependent (Sanjay et al., 2001). In this
regard, the intracellular calcium chelator, BAPTA, blunts
Pyk2 autophosphorylation in  3
 /  and  3
 /  pre-OCs.
Second, other adhesive receptors could compensate for the
lack of  3 and mediate Pyk2 phosphorylation. Pyk2 activa-
tion occurs equally in cells lacking  2 1 integrin or CD44,
another receptor for OPN, but not in  2
 /  pre-OCs.
Thus, although it is formally possible that  2 1, CD44,
and  3 compensate for each other in signaling to Pyk2, the
weak Pyk2 phosphorylation detected in  2
 /  cells suggests
that the  2 integrin is dominant in this process. In support
of this posture, uncommitted macrophages, which have yet
to express  v 3, activate Pyk2 by  2 integrin ligation
(Duong and Rodan, 2000), and we find that the same is true
in  3
 /  pre-OCs. Despite having the  2 integrin,  3
 / 
pre-OCs generated in high dose M-CSF do not retain a
macrophage phenotype, as they express markers of commit-
ted OCs. As the  2 integrin is not present in fully mature
resorptive OCs (Athanasou and Quinn, 1990), in this cir-
cumstance,  v 3 may be the Pyk2 activating receptor.
Pyk2, independent of its phosphorylation status, is associ-
ated with paxillin, and this association is increased in adher-
ent cells. Pyk2, however, fails to be recruited to the  3 com-
Figure 10. Model of OC  v 3 integrin activation and signal 
transduction. (A)  v 3 in its basal conformation (||) exists within 
the actin ring. Resorption is stimulated by growth factors and 
requires activated  v 3 ( ), which localizes in newly formed 
membrane extensions. (B) Binding of a growth factor (GF) to its 
receptor changes the conformation of the external domain of  v 3 
from the basal to the activated state. The GF receptor tyrosine kinase 
(RTK) and  v 3 collaboratively induce cytoskeletal rearrangements 
via activation of Rho family proteins from their GDP-bound to 
GTP-bound forms. Pyk2 is phosphorylated (*) by  M 2 binding an 
unknown ligand (?) or increased intracellular calcium. Upon ligand 
(RGD) occupancy of  v 3, phosphorylated (*) Pyk2 forms a complex 
at the  3 cytoplasmic domain with phosphorylated c-Src and c-Cbl. 
Whereas Pyk2 is constitutively associated with paxillin, formation of 
the Pyk2–c-Src–c-Cbl adhesive complex, and thus efficient bone 
resorption, requires  v 3.T
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plex in adherent cells carrying  3- C or S
752P. It is possible
that the failure of c-Src and c-Cbl to be activated in these
mutants reflects the inability of Pyk2 to bind the integrin.
We propose, therefore, that in OCs, cytokines stimulate
the formation of new membrane extensions that contain ac-
tivated  v 3 (Fig. 10 A). These cytoskeletal rearrangements
are under the control of Rho family GTPases and require
functional  v 3 (Fig. 10 B). Upon  v 3 occupancy, phos-
phorylated Pyk2, an event independent of the integrin,
forms a complex at the  3 cytoplasmic domain with phos-
phorylated c-Src and c-Cbl (Fig. 10 B). In the absence of
functional  v 3, Pyk2 may be activated by other means,
such as  M 2 or increased calcium. These alternative means
of activating Pyk2 permit its association with paxillin, but
the Pyk2–c-Src–c-Cbl adhesive complex fails to form, result-
ing in poorly resorptive OCs.
Materials and methods
Murine OCs
BMMs were isolated from long bones of 4- to 8-wk-old mice by culturing
whole marrow for 3 d in  -MEM containing 10% heat-inactivated FBS and
1:10 CMG supernatant as a source of M-CSF (Faccio et al., 2003).
Infection of BMMs
BMMs were transduced with virus containing vectors that encode for sev-
eral  3 integrin mutants (Feng et al., 2001), in the presence of 1:10 CMG
supernatant and 8  g/ml polybrene (Sigma-Aldrich), without antibiotic se-
lection. Cells were cultured for an additional 2–3 d before analysis of inte-
grin expression or osteoclastogenesis.
Flow cytometry
Pre-OCs expressing the different mutants were lifted with Trypsin/EDTA
(Sigma-Aldrich) and washed in a calcium-free buffer based on HBSS. Pre-
treated cells were incubated with HGF or M-CSF in  -MEM supplemented
with 0.5% BSA for 30 min at 37 C; control cells were incubated with me-
dium alone. After incubation, cells were washed twice and incubated with
the mAb AP5 (50  g/ml) in high calcium buffer, which recognizes the acti-
vated  3 integrin subunit. Binding of AP5 in HBSS calcium-free buffer
served as positive control, identifying all  3 on the cell surface. Cells were
then incubated with FITC-conjugated secondary Ab, as previously de-
scribed (Faccio et al., 2002).
Immunofluorescence
 3
 /  or  3
 /  BMMs, transduced with the indicated mutants, were plated
on dentin slices or glass coverslips under osteoclastogenic conditions for
4 d. For some experiments (Figs. 3 and 4), after 4 d in culture, cells were
treated with HGF (50 ng/ml) or M-CSF (100 ng/ml), or media   0.5% BSA
as control, for 30 min at 37 C, and then fixed and stained as previously de-
scribed (Faccio et al., 2002) and observed with a confocal microscope.
Adhesion and migration assays
Adhesion and haptotactic migration assays were performed using pre-OCs
expressing the different  3 mutants plated respectively onto 96-well
plates or transwell filters, 8- m pore size (Costar), coated with 10  g/ml
human OPN.
For both experiments, cells were preactivated with growth factors or
AP5 for 30 min in suspension and then plated, and adherent cells were
stained with crystal violet. For migration assay, cells that migrated to the
lower side were viewed at 300  magnification and counted. Results rep-
resent the averages from 15 fields   SEM of a representative experiment.
Western blot analysis
BMMs were cultured for 3 d in the presence of 100 ng/ml RANKL and 100
ng/ml M-CSF and starved overnight in the presence of 2% serum. Cells
were lifted and replated onto the indicated matrix proteins for 30 or 60
min. In some experiments, adherent OCs were starved and restimulated
with 100 ng/ml M-CSF or 50 ng/ml HGF. Cells were lysed in RIPA (Faccio
et al., 2003), or in TNE (Lakkakorpi et al., 1999) for coimmunoprecipita-
tion of c-Src and Pyk2. Precleared lysates were immunoprecipitated with 2
 g anti-Pyk2 polyclonal antibodies (Biosource International, CA), 2  g
anti- 3 mAb (clone 7G2), or 2  g antiphosphotyrosines (PY99) for 1 h at
4 C followed by overnight incubation with protein A/G–Sepharose beads
at 4 C (Santa Cruz Biotechnology, Inc.) and then analysis by SDS-PAGE
and immunoblotting.
Rho and Rac assay
Pre-OCs were lysed in a buffer containing 50 mM Tris/HCl, pH 7.5, 1 mM
EDTA, 500 mM NaCl, 10 mM MgCl2, 1% (vol/vol) Triton X-100, and pro-
tease inhibitors (4  g/ml leupeptin and 30  g/ml PMSF). Lysates were in-
cubated with glutathione–agarose beads (Sigma-Aldrich) coupled with
bacterially expressed GST–RBD fusion protein for Rho pull down or GST–
PAK1 for Rac pull down (Ren et al., 1999) at 4 C for 45 min. Bound pro-
teins were analyzed by SDS-PAGE followed by immunoblotting against
RhoA (Santa Cruz Biotechnology, Inc.) or Rac1 (Upstate Biotechnology).
Online supplemental material
The supplemental material (Figs. S1 and S2) is available at http://
www.jcb.org/cgi/content/full/jcb.200212082/DC1. Fig. S1 shows the ex-
pression levels of c-Fms,  2 1, and  2 in BMMs and pre-OCs. Fig. S2
shows the localization of viniculin, talin, and  3 integrin in the podosomes.
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